Cargando…
Implementation of sorafenib treatment for advanced hepatocellular carcinoma: an illustration of current practice in Taiwan
BACKGROUND: Sorafenib is the first regimen listed in the treatment algorithm for hepatocellular carcinoma (HCC) worldwide. This study aimed to assess the efficacy of sorafenib treatment for advanced HCC in a clinical practice using a nationwide population study. METHODS: All patients registered with...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349081/ https://www.ncbi.nlm.nih.gov/pubmed/30774429 http://dx.doi.org/10.2147/CMAR.S186678 |